References
- Amar, S., Kitabgi, P., & Vincent, J. P. (1987). Stimulation of inositol phosphate production by neurotensin in neuroblastoma N1E115 cells: Implication of GTP-binding proteins and relationship with the cyclic GMP response. Journal of Neurochemistry, 49(4), 999–1006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/3040912. doi: 10.1111/j.1471-4159.1987.tb09986.x
- Ballesteros, J. A., Jensen, A. D., Liapakis, G., Rasmussen, S. G., Shi, L., Gether, U., & Javitch, J. A. (2001). Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. Journal of Biological Chemistry, 276(31), 29171–29177. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11375997. doi: 10.1074/jbc.M103747200
- Ballesteros, J. A., & Weinstein, H. (1995). [19] Integrated methods for the construction of three-dimensional models and computational probing of structure–function relations in G protein-coupled receptors. In S. C. Sealfon (Ed.), Methods in neurosciences (Vol. 25, pp. 366–428). Cambridge, MA: Academic Press.
- Barroso, S., Richard, F., Nicolas-Etheve, D., Kitabgi, P., & Labbe-Jullie, C. (2002). Constitutive activation of the neurotensin receptor 1 by mutation of Phe(358) in Helix seven. British Journal of Pharmacology, 135(4), 997–1002. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11861328. doi: 10.1038/sj.bjp.0704546
- Barroso, S., Richard, F., Nicolas-Ethève, D., Reversat, J.-L., Bernassau, J.-M., Kitabgi, P., & Labbé-Jullié, C. (2000). Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1. Journal of Biological Chemistry, 275(1), 328–336. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10617622. doi: 10.1074/jbc.275.1.328
- Bissette, G., Nemeroff, C. B., Loosen, P. T., Prange, A. J., Jr., & Lipton, M. A. (1976). Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature, 262(5569), 607–609. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8728. doi: 10.1038/262607a0
- Brooks, B. R., Brooks, C. L., Mackerell, A. D., Nilsson, L., Petrella, R. J., Roux, B., … Karplus, M. (2009). CHARMM: The biomolecular simulation program. Journal of Computational Chemistry, 30(10), 1545–1614. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19444816. doi: 10.1002/jcc.21287
- Chabry, J., Labbe-Jullie, C., Gully, D., Kitabgi, P., Vincent, J. P., & Mazella, J. (1994). Stable expression of the cloned rat brain neurotensin receptor into fibroblasts: Binding properties, photoaffinity labeling, transduction mechanisms, and internalization. Journal of Neurochemistry, 63(1), 19–27. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8207427. doi: 10.1046/j.1471-4159.1994.63010019.x
- Chalon, P., Vita, N., Kaghad, M., Guillemot, M., Bonnin, J., Delpech, B., … Caput, D. (1996). Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Letters, 386(2-3), 91–94. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8647296. doi: 10.1016/0014-5793(96)00397-3
- Che, T., Majumdar, S., Zaidi, S. A., Ondachi, P., McCorvy, J. D., Wang, S., … Roth, B. L. (2018). Structure of the nanobody-stabilized active state of the kappa opioid receptor. Cell, 172(1–2), 55–67.E15. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/29307491. doi: 10.1016/j.cell.2017.12.011
- Chun, E., Thompson, A. A., Liu, W., Roth, C. B., Griffith, M. T., Katritch, V., … Stevens, R. C. (2012). Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure, 20(6), 967–976. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22681902. doi: 10.1016/j.str.2012.04.010
- Clineschmidt, B. V., McGuffin, J. C., & Bunting, P. B. (1979). Neurotensin: Antinocisponsive action in rodents. European Journal of Pharmacology, 54(1–2), 129–139. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/421735. doi: 10.1016/0014-2999(79)90415-1
- Cong, X., Fiorucci, S., & Golebiowski, J. (2018). Activation dynamics of the neurotensin G protein-coupled receptor 1. Journal of Chemical Theory and Computation, 14(8), 4467–4473. doi:10.1021/acs.jctc.8b00216. Retrieved from doi: 10.1021/acs.jctc.8b00216
- Deupi, X., & Standfuss, J. (2011). Structural insights into agonist-induced activation of G-protein-coupled receptors. Current Opinion in Structural Biology, 21(4), 541–551. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21723721. doi: 10.1016/j.sbi.2011.06.002
- Dubuc, I., Sarret, P., Labbé-Jullié, C., Botto, J. M., Honoré, E., Bourdel, E., … Mazella, J. (1999). Identification of the receptor subtype involved in the analgesic effect of neurotensin. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 19(1), 503–510. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9870978. doi: 10.1523/JNEUROSCI.19-01-00503.1999
- Egloff, P., Hillenbrand, M., Klenk, C., Batyuk, A., Heine, P., Balada, S., … Plückthun, A. (2014). Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli. Proceedings of the National Academy of Sciences, 111(6), E655–E662. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24453215. doi: 10.1073/pnas.1317903111
- Gui, X., Liu, S., Yan, Y., & Gao, Z. (2013). Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia. World Journal of Gastroenterology, 19(28), 4504–4510. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23901225. doi: 10.3748/wjg.v19.i28.4504
- Holst, B., Nygaard, R., Valentin-Hansen, L., Bach, A., Engelstoft, M. S., Petersen, P. S., … Schwartz, T. W. (2010). A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors. Journal of Biological Chemistry, 285(6), 3973–3985. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19920139. doi: 10.1074/jbc.M109.064725
- Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38, 27–28. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8744570. doi: 10.1016/0263-7855(96)00018-5
- Jacobsen, L., Madsen, P., Jacobsen, C., Nielsen, M. S., Gliemann, J., & Petersen, C. M. (2001). Activation and functional characterization of the mosaic receptor SorLA/LR11. Journal of Biological Chemistry, 276(25), 22788–22796. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11294867. doi: 10.1074/jbc.M100857200
- Kirchberg, K., Kim, T.-Y., Moller, M., Skegro, D., Dasara Raju, G., Granzin, J., … Alexiev, U. (2011). Conformational dynamics of helix 8 in the GPCR rhodopsin controls arrestin activation in the desensitization process. Proceedings of the National Academy of Sciences USA, 108(46), 18690–18695. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22039220. doi: 10.1073/pnas.1015461108
- Kisselev, O. G., & Downs, M. A. (2006). Rhodopsin-interacting surface of the transducin gamma subunit. Biochemistry, 45(31), 9386–9392. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16878973. doi: 10.1021/bi060806x
- Klauda, J. B., Venable, R. M., Freites, J. A., O’Connor, J. W., Tobias, D. J., Mondragon-Ramirez, C., … Pastor, R. W. (2010). Update of the CHARMM all-atom additive force field for lipids: Validation on six lipid types. The Journal of Physical Chemistry B, 114(23), 7830–7843. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20496934. doi: 10.1021/jp101759q
- Kleczkowska, P., & Lipkowski, A. W. (2013). Neurotensin and neurotensin receptors: Characteristic, structure–activity relationship and pain modulation – A review. European Journal of Pharmacology, 716(1-3), 54–60. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23500196. doi: 10.1016/j.ejphar.2013.03.004
- Kling, R. C., Plomer, M., Lang, C., Banerjee, A., Hubner, H., & Gmeiner, P. (2016). Development of covalent ligand–receptor pairs to study the binding properties of nonpeptidic neurotensin receptor 1 antagonists. ACS Chemical Biology, 11(4), 869–875. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26808719. doi: 10.1021/acschembio.5b00965
- Krumm, B. E., Lee, S., Bhattacharya, S., Botos, I., White, C. F., Du, H., …., Grisshammer, R. (2016). Structure and dynamics of a constitutively active neurotensin receptor. Scientific Report, 6, 38564. doi: 10.1038/srep38564 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27924846
- Krumm, B. E., White, J. F., Shah, P., & Grisshammer, R. (2015). Structural prerequisites for G-protein activation by the neurotensin receptor. Nature Communications, 6, 7895. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26205105. doi: 10.1038/ncomms8895
- Labbe-Jullie, C., Barroso, S., Nicolas-Eteve, D., Reversat, J. L., Botto, J. M., Mazella, J., … Kitabgi, P. (1998). Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist. Journal of Biological Chemistry, 273(26), 16351–16357. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9632698. doi: 10.1074/jbc.273.26.16351
- Labbe-Jullie, C., Dubuc, I., Brouard, A., Doulut, S., Bourdel, E., Pelaprat, D. …. (1994). In vivo and in vitro structure–activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes. Journal of Pharmacology and Experimental Therapeutics, 268(1), 328–336. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8301574
- Lee, J., Cheng, X., Swails, J. M., Yeom, M. S., Eastman, P. K., Lemkul, J. A., … Im, W. (2016). CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. Journal of Chemical Theory and Computation, 12(1), 405–413. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26631602. doi: 10.1021/acs.jctc.5b00935
- Lee, S., Bhattacharya, S., Tate, C. G., Grisshammer, R., & Vaidehi, N. (2015). Structural dynamics and thermostabilization of neurotensin receptor 1. The Journal of Physical Chemistry B, 119(15), 4917–4928. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25807267. doi: 10.1021/jp510735f
- MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., … Karplus, M. (1998). All-atom empirical potential for molecular modeling and dynamics studies of proteins. The Journal of Physical Chemistry B, 102(18), 3586–3616. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24889800. doi: 10.1021/jp973084f
- Mackerell Jr., A. D., Feig, M., & Brooks, C. L. 3rd. (2004). Extending the treatment of backbone energetics in protein force fields: Limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. Journal of Computational Chemistry, 25(11), 1400–1415. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15185334. doi: 10.1002/jcc.20065
- Martin, C., Moors, S. L. C., Danielsen, M., Betti, C., Fabris, C., Sejer Pedersen, D., … Ballet, S. (2017). Rational design of nanobody80 loop peptidomimetics: Towards biased beta2 adrenergic receptor ligands. Chemistry – A European Journal, 23(40), 9632–9640. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28449310. doi: 10.1002/chem.201701321
- Mazella, J., Botto, J. M., Guillemare, E., Coppola, T., Sarret, P., & Vincent, J. P. (1996). Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. The Journal of Neuroscience, 16(18), 5613–5620. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8795617. doi: 10.1523/JNEUROSCI.16-18-05613.1996
- Mazella, J., Zsürger, N., Navarro, V., Chabry, J., Kaghad, M., Caput, D., … Vincent, J. P. (1998). The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. The Journal of Biological Chemistry, 273(41), 26273–26276. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9756851. doi: 10.1074/jbc.273.41.26273
- Nawaratne, V., Leach, K., Felder, C. C., Sexton, P. M., & Christopoulos, A. (2010). Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: Identification of ligand-specific and global activation mechanisms. Journal of Biological Chemistry, 285(25), 19012–19021. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20406819. doi: 10.1074/jbc.M110.125096
- Osadchii, O., Norton, G., Deftereos, D., Badenhorst, D., & Woodiwiss, A. (2005). Impact and mechanisms of action of neurotensin on cardiac contractility in the rat left ventricle. European Journal of Pharmacology, 520(1-3), 108–117. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16154127. doi: 10.1016/j.ejphar.2005.07.014
- Ouyang, Q., Gong, X., Xiao, H., Zhou, J., Xu, M., Dai, Y., … Yi, L. (2015). Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients. Molecular Cancer, 14(1), 21. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25644759. doi: 10.1186/s12943-015-0290-8
- Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera – a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15264254. doi: 10.1002/jcc.20084
- Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., … Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781–1802. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16222654. doi: 10.1002/jcc.20289
- Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., … Kobilka, B. K. (2011). Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor. Nature, 469(7329), 175–180. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21228869. doi: 10.1038/nature09648
- Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., … Kobilka, B. K. (2011). Crystal structure of the beta2 adrenergic receptor–Gs protein complex. Nature, 477(7366), 549–555. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21772288. doi: 10.1038/nature10361
- Richard, F., Barroso, S., Nicolas-Etheve, D., Kitabgi, P., & Labbe-Jullie, C. (2001). Impaired G protein coupling of the neurotensin receptor 1 by mutations in extracellular loop 3. European Journal of Pharmacology, 433(1), 63–71. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11755135. doi: 10.1016/S0014-2999(01)01496-0
- Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., … Kobilka, B. K. (2007). GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science, 318(5854), 1266–1273. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17962519. doi: 10.1126/science.1150609
- Sali, A., & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology, 234(3), 779–815. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8254673. doi: 10.1006/jmbi.1993.1626
- Shibata, Y., Gvozdenovic-Jeremic, J., Love, J., Kloss, B., White, J. F., Grisshammer, R., & Tate, C. G. (2013). Optimising the combination of thermostabilising mutations in the neurotensin receptor for structure determination. Biochimica et Biophysica Acta, 1828(4), 1293–1301. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23337476. doi: 10.1016/j.bbamem.2013.01.008
- Shibata, Y., White, J. F., Serrano-Vega, M. J., Magnani, F., Aloia, A. L., Grisshammer, R., & Tate, C. G. (2009). Thermostabilization of the neurotensin receptor NTS1. Journal of Molecular Biology, 390(2), 262–277. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19422831. doi: 10.1016/j.jmb.2009.04.068
- Standfuss, J., Edwards, P. C., D’Antona, A., Fransen, M., Xie, G., Oprian, D. D., & Schertler, G. F. X. (2011). The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature, 471(7340), 656–660. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21389983. doi: 10.1038/nature09795
- Tanaka, K., Masu, M., & Nakanishi, S. (1990). Structure and functional expression of the cloned rat neurotensin receptor. Neuron, 4(6), 847–854. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1694443. doi: 10.1016/0896-6273(90)90137-5
- Tate, C. G. (2012). A crystal clear solution for determining G-protein-coupled receptor structures. Trends in Biochemical Sciences, 37(9), 343–352. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22784935. doi: 10.1016/j.tibs.2012.06.003
- Tyler-McMahon, B. M., Boules, M., & Richelson, E. (2000). Neurotensin: Peptide for the next millennium. Regulatory Peptides, 93(1–3), 125–136. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11033059. doi: 10.1016/S0167-0115(00)00183-X
- Vita, N., Laurent, P., Lefort, S., Chalon, P., Dumont, X., Kaghad, M., … Caput, D. (1993). Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Letters, 317(1–2), 139–142. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8381365. doi: 10.1016/0014-5793(93)81509-X
- Wang, X., Kim, S. H., Ablonczy, Z., Crouch, R. K., & Knapp, D. R. (2004). Probing rhodopsin–transducin interactions by surface modification and mass spectrometry. Biochemistry, 43(35), 11153–11162. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15366925. doi: 10.1021/bi049642f
- White, J. F., Noinaj, N., Shibata, Y., Love, J., Kloss, B., Xu, F., … Grisshammer, R. (2012). Structure of the agonist-bound neurotensin receptor. Nature, 490(7421), 508–513. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23051748. doi: 10.1038/nature11558
- Younes, M., Wu, Z., Dupouy, S., Lupo, A. M., Mourra, N., Takahashi, T., …., Forgez, P. (2014). Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib. Oncotarget, 5(18), 8252–8269. doi: 10.18632/oncotarget.1633Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25249545
- Zhao, D., & Pothoulakis, C. (2006). Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation. Peptides, 27(10), 2434–2444. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16872719. doi: 10.1016/j.peptides.2005.12.016
- Zogovic, B., & Pilowsky, P. M. (2012). Intrathecal neurotensin is hypotensive, sympathoinhibitory and enhances the baroreflex in anaesthetized rat. British Journal of Pharmacology, 166(1), 378–389. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22035146. doi: 10.1111/j.1476-5381.2011.01760.x